drugset / Trial / NCT00153166

ARREST PAD (Peripheral Arterial Disease)

NCT00153166

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial will test the hypothesis that inflammation and insulin resistance contribute to reduced walking distance in subjects with intermittent claudication by impairing vascular reactivity and skeletal muscle metabolic function.

Timeline

Start
2004-01
Primary completion
2010-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg Oral
Subject Pioglitazone Small molecule 30 mg Oral